Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Apr-24 8:30 AM View:  | Access Pharmaceuticals Inc. (ABEO) | 25-Apr-24 | Purchase | 5,608 | $3.14 | $17,609.10 | 2% 228.26K to 233.87K | |
| 15-Mar-24 5:00 PM View: | Access Pharmaceuticals Inc. (ABEO) | 15-Mar-24 | Payment of Exercise | 703 | $8.14 | $5,722.42 | (< 1%) 228.96K to 228.26K | |
| 29-Sep-23 5:17 PM View: | Access Pharmaceuticals Inc. (ABEO) | 29-Sep-23 | Payment of Exercise | 6,230 | $3.93 | $24,483.90 | (3%) 235.19K to 228.96K | |
| 20-Sep-23 9:00 AM View: | Access Pharmaceuticals Inc. (ABEO) | 19-Sep-23 | Purchase | 3,000 | $3.82 | $11,458.30 | 1% 235.18K to 238.18K | |
| 25-Jul-23 8:10 PM View: | Access Pharmaceuticals Inc. (ABEO) | 24-Jul-23 | Payment of Exercise | 1,187 | $3.73 | $4,427.51 | (< 1%) 236.37K to 235.18K | |
| 07-Jun-23 4:15 PM View: | Access Pharmaceuticals Inc. (ABEO) | 05-Jun-23 | Grant | 141,908 | -- | -- | 150% 94.46K to 236.37K | |
| 17-Mar-23 4:05 PM View: | Access Pharmaceuticals Inc. (ABEO) | 15-Mar-23 | Payment of Exercise | 792 | $2.60 | $2,059.20 | (< 1%) 95.25K to 94.46K | |
| 21-Nov-22 9:00 AM View: | Access Pharmaceuticals Inc. (ABEO) | 18-Nov-22 | Purchase | 2,500 | $4.00 | $10,000.00 | 3% 92.75K to 95.25K | |
| 30-Sep-22 4:05 PM View: | Access Pharmaceuticals Inc. (ABEO) | 28-Sep-22 | Grant | 72,750 | -- | -- | 364% 20.0K to 92.75K | |
| 25-Jul-22 6:17 PM View: | Access Pharmaceuticals Inc. (ABEO) | 21-Jul-22 | Grant | 12,000 | -- | -- | 150% 8.0K to 20.0K | |
| 16-Mar-22 4:08 PM View: | Access Pharmaceuticals Inc. (ABEO) | 14-Mar-22 | Grant | 200,000 | -- | -- | 100% 0 to 200.0K | |
| 20-Dec-21 5:07 PM View: | Avenue Therapeutics, Inc. (ATXI) | 17-Dec-21 | Grant | 100,505 | -- | -- | 154% 65.25K to 165.76K | |
| 15-Sep-21 4:03 PM View: | Avenue Therapeutics, Inc. (ATXI) | 15-Sep-21 | Market Sale | 7,160 | $1.62 | $11,599.20 | (10%) 72.41K to 65.25K | (7%) |
| 21-Aug-20 4:15 PM View: | Avenue Therapeutics, Inc. (ATXI) | 20-Aug-20 | Market Sale | 3,840 | $12.13 | $46,579.20 | (6%) 61.25K to 57.41K | 45% |
| 10-Mar-20 4:42 PM View: | Avenue Therapeutics, Inc. (ATXI) | 10-Mar-20 | Market Purchase | 1,889 | $7.94 | $14,998.70 | 3% 59.36K to 61.25K | (16%) |
| 10-Mar-20 4:42 PM View: | Avenue Therapeutics, Inc. (ATXI) | 09-Mar-20 | Market Purchase | 1,500 | $7.99 | $11,983.00 | 3% 57.86K to 59.36K | (17%) |
| 25-Feb-20 4:55 PM View: | Avenue Therapeutics, Inc. (ATXI) | 25-Feb-20 | Market Purchase | 1,200 | $9.09 | $10,908.00 | 2% 56.66K to 57.86K | (27%) |
| 12-Aug-19 4:19 PM View: | Avenue Therapeutics, Inc. (ATXI) | 09-Aug-19 | Market Sale | 2,375 | $5.56 | $13,205.00 | (4%) 59.04K to 56.66K | (20%) |
| 12-Aug-19 4:19 PM View: | Avenue Therapeutics, Inc. (ATXI) | 08-Aug-19 | Market Sale | 2,313 | $5.62 | $12,999.10 | (4%) 61.35K to 59.04K | (19%) |
| 08-Aug-18 9:50 PM View: | Avenue Therapeutics, Inc. (ATXI) | 07-Aug-18 | Gift | 30,000 | -- | -- | 96% 31.35K to 61.35K | |
| 28-Jun-18 1:09 PM View: | Avenue Therapeutics, Inc. (ATXI) | 28-Jun-18 | Grant | 1,351 | $3.66 | $4,944.66 | 5% 30.0K to 31.35K | 82% |